Objective : The purpose of this study was to detect the expression of hsa_circ_0068631 which is generated from TFRC in BC and to evaluate the relationship between hsa_circ_0068631 expression and the clinical pathological variables of sixty patients.Also the aim of this study was to unveil the potential molecular mechanism of hsa_circ_006863 in the progress of BC,which might provide a scientific basis for hsa_circ_0068631 as a novel molecular target for clinical diagnosis and treatment of BC.Methods:(1)Hsa_circ_0068631 was identified by Sanger sequencing,RNase enzyme digestion and Actinomycin D assay.(2)Reverse Transcription polymerase chain reaction(RT-q PCR)was used to detect the relative expression of hsa_circ_0068631 in sixty BC tissues.The relationship between hsa_circ_0068631 expression and the clinical pathological variables of sixty patients was analyzed.(3)RT-q PCR was used to detect the relative expression of hsa_circ_0068631 in six cell lines(MDA-MB-231、HCC-1937、 BT 549、SKBR3、MCF-7、MCF-10A).FISH analysis and nuclear-cytoplasmic fractionation assay were performed to explore the cellular distribution of hsa_circ_0068631.(4)MDA-MB-231 and MCF-7 were chosen for subsequent experiments.The proliferation of BC cells influenced by depletion or overexpression of hsa_circ_0068631 was detected by the MTT assay and colony formation assay.The migration of BC cells influenced by depletion or overexpression of hsa_circ_0068631 was detected by transwell migration assay and wound healing assays.Cell cycle influenced by depletion of hsa_circ_0068631 was further tested by flow cytometry analysis.(5)Xenograft tumor assay was carried out in mice to observe the tumorigenesis of MDA-MB-231 cells stably infected by LV-circ_0068631 or LV-vector.(6)Bioinformatic methods were employed to analyze the possible binding RBP of hsa_circ_0068631 and downstream target of RBP.The binding of hsa_circ_0068631 and RBP,RBP and downstream target was detected by RIP and RNA pull down.(7)Western Blot was used to detect the expression of RBP in BC cell lines.RT-q PCR was used to detect the relative expression of downstream m RNA in sixty BC tissues.(8)Western Blot and RT-q PCR were used to detect the effect of depletion or overexpression of hsa_circ_0068631 on protein and m RNA levels of RBP and downstream target.(9)RT-q PCR was used to detect the influence on the biding of RBP and target gene by depletion of hsa_circ_0068631.(10)Actinomycin D assay was used to detect the influence on the stability of downstream m RNA by depletion of hsa_circ_0068631 or RBP.Results:(1)The back-splicing junction site of exon 3 toward exon 2 of hsa_circ_0068631 was verified by Sanger sequencing.RNase enzyme digestion and Actinomycin D assay showed that hsa_circ_0068631 was indeed circular.(2)The expression of hsa_circ_0068631 in BC tissues(n=60)was significantly higher than that in adjacent normal tissues.High expression of hsa_circ_0068631 was positively associated with TNM stage,tumor size,lymph node metastasis and distant metastasis,but had no correlation with age.(3)5 BC cell lines(MDA-MB-231,MCF-7,HCC-1937,BT549 and SKBR3)presented higher hsa_circ_0068631 expression compared with MCF-10 A.FISH analysis and nuclear-cytoplasmic fractionation assay showed that hsa_circ_0068631 was enriched in the cytoplasm.(4)MTT assays and colony formation assay results showed that hsa_circ_0068631-overexpression significantly promoted BC cells proliferation.BC cell migration was enhanced by upregulation of hsa_circ_0068631.The opposite results were obtained when the expression of hsa_circ_0068631 was downregulated.Flow cytometry showed that the downregulation of hsa_circ_0068631 caused cell cycle arrest.(5)The results of animal experiment showed that the volume and weight of breast cancer in the LV-circ_0068631 group were increased.(6)According to the prediction of Circ Interactome,hsa_circ_0068631 had a binding site with EIF4A3.The binding of hsa_circ_0068631 and EIF4A3 was confirmed by RIP and RNA pull down.According to the systematic analysis of co-expression network of EIF4A3 in cancers,biological pathway showed c-Myc pathway was enriched among EIF4A3 co-expressed partners.The binding of c-Myc and EIF4A3 and was confirmed by RIP and RNA pull down.(7)EIF4A3 was highly expressed in BC cell lines.The expression of c-Myc m RNA in BC tissues was significantly higher than that in adjacent normal tissues.(8)No significant changes were found in both m RNA and protein levels of EIF4A3 with hsa_circ_0068631 depletion or overexpression.The protein level of c-Myc was positively regulated by hsa_circ_0068631 but the m RNA level of c-Myc had no changes.Given that cyclin E and CDK4 were confirmed target genes of c-Myc,we found that both cyclin E and CDK4 protein levels were positively regulated by hsa_circ_0068631.(9)The biding of EIF4A3 and c-Myc decresed with hsa_circ_0068631 depletion.(10)In actinomycin D assay c-Myc m RNA stability was reduced due to hsa_circ_0068631 depletion or EIF4A3 depletion.EIF4A3 overexpression rescued c-Myc m RNA stability decrease induced by hsa_circ_0068631 depletion in BC cells.Conclusion : In conclusion,our results demonstrate that the expression of hsa_circ_0068631 in BC tissues and cell lines is up-regulated.The high expression of hsa_circ_0068631 is associated with the clinical pathological variables.We prove that hsa_circ_0068631 might be a new oncogene.The upregulation of hsa_circ_0068631could facilitate the progression of BC by binding to EIF4A3 to maintain c-Myc m RNA stability.Suppressing hsa_circ_0068631/EIF4A3/c-Myc axis represents a potential strategy for BC. |